Oppenheimer reaffirmed their buy rating on shares of Amedisys (NASDAQ:AMED) in a report released on Monday, AnalystRatings.com reports. Oppenheimer currently has a $215.00 target price on the health s
Amedisys Inc (NASDAQ:AMED) – Equities research analysts at Jefferies Financial Group issued their Q1 2020 EPS estimates for Amedisys in a research note issued on Tuesday, April 28th. Jefferies Finan
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the BofA
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

10 Stocks to Buy for an Aging Population

03:00pm, Tuesday, 28'th Apr 2020
Aging seniors have been put firmly in the crosshairs of the novel coronavirus. These 10 stocks to buy will benefit from this brutal reality.
Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including American Tower, Ferrari and Walt Disney, on Tuesday. HIGHLIGHTS * Amer
NEW YORK, April 28, 2020 -- The world isn't just battling a health pandemic, but additionally a financial one, as the Novel Coronavirus (COVID – 19) throws its long shadow over.
The "Nursing Care Market in US - Industry Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The US Nursing Care Market is expected to grow at a CAGR of o
The "Nursing Care Market in US - Industry Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Amedisys (AMED) today and set a price target of $215.00. The company's shares closed
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Amedisys ( AMED – Research Report ) today and set a price target of $215.00 . The company’s shares closed last Friday at $186.50.
Amedisys to acquire AseraCare Hospice for $235M in cash AMED
Pre-open movers U.S. stock futures traded higher in early pre-market trade, ahead of earnings from Lincoln Electric Holdings, Inc. (NASDAQ: LECO), PPG Industries, Inc. (NYSE:...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE